Date | Opp | DKSAL | FDSAL | DKFPTS | FDFPTS | fuml | ruypc | att | 2ptpa | payds | patd | krtd | int | 2ptre | ruatt | tchs | ruyds | cmp | rutd | putd | tar | fumtd | rec | 2ptru | rzatt | pct | rztar | reypc | reyds | tyds | retd |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-24 | vs. TB | $4.6K | $5.3K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2024-11-10 | @ CAR | $4.8K | $5.9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2024-11-03 | vs. WAS | $4.8K | $5.6K | 9 | 7.5 | 0 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 11 | 0 | 0 | 0 | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 100 | 49 | 60 | 0 |
2024-10-28 | @ PIT | $4.8K | $5.7K | 17.8 | 15.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 7 | 0 | 4 | 0 | 0 | 0 | 0 | 57.1 | 108 | 108 | 0 |
2024-10-20 | vs. PHI | $5.1K | $6K | 2.1 | 1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 33.3 | 11 | 11 | 0 |
2024-10-13 | vs. CIN | $4.6K | $5.9K | 11.7 | 8.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 11 | 0 | 6 | 0 | 0 | 0 | 0 | 54.5 | 57 | 57 | 0 |
2024-10-06 | @ SEA | $3.9K | $5K | 29.2 | 25.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 11 | 0 | 8 | 0 | 0 | 0 | 0 | 72.7 | 122 | 122 | 1 |
2024-09-26 | vs. DAL | $3.7K | $4.6K | 8.6 | 7.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 5 | 0 | 3 | 0 | 0 | 0 | 0 | 60 | 56 | 56 | 0 |
2024-09-22 | @ CLE | $3.9K | $4.8K | 1.7 | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 50 | 7 | 7 | 0 |
2024-09-15 | @ WAS | $4.1K | $4.8K | 6.3 | 4.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 4 | 0 | 3 | 0 | 0 | 0 | 0 | 75 | 33 | 33 | 0 |
2024-09-08 | vs. MIN | $4.4K | $4.2K | 5.6 | 4.1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 4 | 0 | 3 | 0 | 0 | 0 | 0 | 75 | 26 | 26 | 0 |
2024-08-24 | @ NYJ | $5.5K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2024-08-17 | @ HOU | $5.5K | $6K | 8.9 | 7.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 100 | 59 | 59 | 0 |
2024-08-08 | vs. DET | $5.5K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2024-01-07 | vs. PHI | $4K | $5.7K | 17.2 | 14.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 7 | 0 | 5 | 0 | 0 | 0 | 0 | 71.4 | 62 | 62 | 1 |
2023-12-31 | vs. LAR | $3.4K | $5.4K | 23.6 | 18.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 6 | 0 | 4 | 0 | 0 | 0 | 0 | 66.7 | 106 | 106 | 1 |
2023-12-25 | @ PHI | $3.4K | $5.4K | 18 | 16.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 3 | 0 | 3 | 0 | 0 | 0 | 0 | 100 | 90 | 90 | 1 |
2023-12-17 | @ NO | $3.1K | $5.5K | 10.3 | 8.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 8 | 0 | 4 | 0 | 0 | 0 | 0 | 50 | 63 | 63 | 0 |
2023-12-11 | vs. GB | $3.3K | $5.5K | 3.4 | 2.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 100 | 14 | 14 | 0 |
2023-11-26 | vs. NE | $3.5K | $5.7K | 3.6 | 2.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 3 | 0 | 2 | 0 | 0 | 0 | 0 | 66.7 | 16 | 16 | 0 |
2023-11-19 | @ WAS | $3.2K | $5.4K | 18.2 | 16.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 5 | 0 | 4 | 0 | 0 | 0 | 0 | 80 | 82 | 82 | 1 |
2023-11-12 | @ DAL | $3.2K | $5.5K | 5.1 | 3.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 4 | 0 | 3 | 0 | 0 | 0 | 0 | 75 | 21 | 21 | 0 |
2023-11-05 | @ LV | $3.2K | $5.4K | 9.9 | 7.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 7 | 0 | 4 | 0 | 0 | 0 | 0 | 57.1 | 59 | 59 | 0 |
2023-10-29 | vs. NYJ | $3.4K | $5.4K | 0.9 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 50 | -1 | -1 | 0 |
2023-10-22 | vs. WAS | $3.7K | $5.7K | 3.2 | 2.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 50 | 22 | 22 | 0 |
2023-10-15 | @ BUF | $4K | $5.6K | 10.9 | 8.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 6 | 0 | 4 | 0 | 0 | 0 | 0 | 66.7 | 69 | 69 | 0 |
2023-10-08 | @ MIA | $4.1K | $5.9K | 5.5 | 4.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 4 | 0 | 2 | 0 | 0 | 0 | 0 | 50 | 35 | 35 | 0 |
2023-10-02 | vs. SEA | $4K | $5.7K | 4.3 | 3.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 3 | 0 | 2 | 0 | 0 | 0 | 0 | 66.7 | 23 | 23 | 0 |
2023-09-21 | @ SF | $4.2K | $5.6K | 6.2 | 4.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 6 | 0 | 3 | 0 | 0 | 0 | 0 | 50 | 32 | 32 | 0 |
2023-09-17 | @ ARI | $4.4K | $5.6K | 9.2 | 7.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 6 | 0 | 3 | 0 | 0 | 0 | 0 | 50 | 62 | 62 | 0 |
2023-09-10 | vs. DAL | $4.2K | $5.3K | 4.5 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 5 | 0 | 3 | 0 | 0 | 0 | 0 | 60 | 15 | 15 | 0 |
2023-08-26 | vs. NYJ | $5.5K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-08-18 | vs. CAR | $5.5K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-08-11 | @ DET | $5.5K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-21 | @ PHI | $4.2K | $5.7K | 1.4 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 5 | 0 | 1 | 0 | 0 | 0 | 0 | 20 | 4 | 4 | 0 |
2023-01-15 | @ MIN | $4.2K | $5.8K | 13.1 | 11.1 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 | 3 | 0 | 0 | 0 | 8 | 0 | 4 | 0 | 0 | 0 | 0 | 50 | 88 | 91 | 0 |
2023-01-08 | @ PHI | $4.6K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-01 | vs. IND | $4.9K | $6.3K | 2.4 | 0.4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 3 | 0 | 2 | 0 | 0 | 0 | 0 | 66.7 | 14 | 14 | 0 |
2022-12-24 | @ MIN | $5.2K | $6.3K | 11.9 | 9.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 6 | 0 | 4 | 0 | 0 | 0 | 0 | 66.7 | 79 | 79 | 0 |
2022-12-18 | @ WAS | $4.9K | $6.2K | 7.3 | 4.8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0 | 7 | 0 | 5 | 0 | 0 | 0 | 0 | 71.4 | 23 | 23 | 0 |
2022-12-11 | vs. PHI | $5.1K | $6.3K | 6.2 | 5.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 3 | 0 | 2 | 0 | 0 | 0 | 0 | 66.7 | 42 | 42 | 0 |
2022-12-04 | vs. WAS | $5.1K | $6.2K | 15 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 8 | 0 | 6 | 0 | 0 | 0 | 0 | 75 | 90 | 90 | 0 |
Darius Slayton Daily Fantasy News, Rankings, Projections
NYG WR Darius Slayton (neck) will be active Week 12; per Mike Garafolo.
NYG WR Darius Slayton (neck) will be active Week 12; per Mike Garafolo.
NYG WR Darius Slayton (neck) doubtful Week 12.
NYG WR Darius Slayton (neck) doubtful Week 12.
NYG WR Darius Slayton (illness) and WR Kenny Golladay (illness) are both expected to play.
NYG WR Darius Slayton (illness) and WR Kenny Golladay (illness) are both expected to play.
NYG WR Darius Slayton (illness) is listed questionable for Week 13.
NYG WR Darius Slayton (illness) is listed questionable for Week 13.
NYG WR Darius Slayton (illness) did not practice Thursday.
NYG WR Darius Slayton (illness) did not practice Thursday.
NYG WR Darius Slayton and RB Antonio Williams are inactive Sunday
NYG WR Darius Slayton and RB Antonio Williams are inactive Sunday
NYG WR Darius Slayton placed on COVID list
Darius Slayton has been placed on the COVID list ahead of the Giants matchup with the Chicago Bears. With Slayton likely sidelined this weekend the Giants wide receiver depth could be tested. Kadarius Toney, John Ross, and Collin Johnson all would be expected to play larger roles in Slayton's absence but all three did not practice today putting their status in question. Kenny Golladay seems to be the only healthy receiver at this point and will remain the top pass-catching option along with Evan Engram also likely to play an increased role. It is tough to trust any members of the New York offense at this point due to the quarterback play of both Jake Fromm and Mike Glennon.
NYG WR Sterling Shepard inactive; WR Darius Slayton, WR John Ross, TE Evan Engram all active Sunday
Darius Slayton, John Ross, and Evan Engram are all available to play Sunday against the Carolina Panthers while Sterling Shepard will not be able to suit up due to a hamstring injury. The Giants will at least have two of their injured receivers available today along with their starting tight end, which is good news in what could be a huge bounce back game for the Giants. However, with Shepard unable to go, Darius Slayton becomes the top receiving option and a good value option with Engram also seeing a bump. It is tough to distinguish between what pieces are usable in the Giants offense at this point and with a tough matchup against a good Panthers defense it might just be best to stay away now that Shepard has been ruled out.
NYG WR Darius Slayton, WR John Ross, and TE Evan Engram are expected to play Sunday; WR Sterling Shepard will be a game-time decision
Darius Slayton, John Ross, and Evan Engram are expected to play Sunday against the Carolina Panthers while Sterling Shepard will be a game-time decision with a hamstring injury. The Giants will at least have two of their injured receivers available today along with their starting tight end, which is good news in what could be a huge bounce back game for the Giants. Sterling Shepard still remains questionable and will have to go through warmups before a decision is made on his availability. Shepard projects as one of the better plays on the slate due to his expected volume. However if he were unable to go, Darius Slayton would become the top receiving option with Engram also seeing a bump. It is tough to distinguish between what pieces are usable in the Giants offense at this point and with a tough matchup against a good Panthers defense it might just be best to stay away if Shepard is unable to suit up.
NYG RB Saquon Barkley, WR Kenny Golladay, WR Kadarius Toney ruled out Sunday; WR Sterling Shepard, WR Darius Slayton, WR John Ross, TE Evan Engram questionable
As expected, Saquon Barkley, Kenny Golladay, and Kadarius Toney have been ruled out for Sunday's matchup with the Carolina Panthers. Sterling Shepard, Darius Slayton, John Ross, and Evan Engram are considered questionable. Devontae Booker is likely set to lead the Giants' backfield once again Sunday with Elijhaa Penny and Gary Brightwell available to back him up. Booker was able to rush for 41 yards on 12 carries last Sunday and caught all 4 of his targets for an additional 28 yards in a tough matchup with the Los Angeles Rams and can be considered a value option again this week. Shepard is expected to garner a large target share (if available) with Slayton expected to serve as the number two option (again, if available). Ross and Dante Pettis are also expected to mix in, though Shepard is the primary DFS target based on his expected volume in a matchup where the Giants are likely going to need to pass the ball to have any success.